Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 3 » Issue 3

Mechanisms of improvement of respiratory failure in patients with COPD treated with NIV

Authors Annabel H Nickol, Nicholas Hart, Nicholas S Hopkinson, Carl-Hugo Hamnegård, John Moxham, et al

Published Date October 2008 Volume 2008:3(3) Pages 453—462

DOI http://dx.doi.org/10.2147/COPD.S2705

Published 12 October 2008

Annabel H Nickol1,2, Nicholas Hart1,3, Nicholas S Hopkinson1, Carl-Hugo Hamnegård4, John Moxham5, Anita Simonds1, Michael I Polkey1

1Respiratory Muscle Laboratory, Royal Brompton Hospital, London, UK; 2Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, UK; 3The Lane Fox Unit, St Thomas’ Hospital, London, UK; 4Department of Pulmonary Medicine and Clinical Physiology, Sahlgrenska University, Gotenborg, Sweden; 5Respiratory Muscle Laboratory, King’s College London School of Medicine, King’s College Hospital, London, UK

Background: Noninvasive ventilation (NIV) improves gas-exchange and symptoms in selected chronic obstructive pulmonary disease (COPD) patients with hypercapnic respiratory failure. We hypothesized NIV reverses respiratory failure by one or all of increased ventilatory response to carbon-dioxide, reduced respiratory muscle fatigue, or improved pulmonary mechanics.

Methods: Nineteen stable COPD patients (forced expiratory volume in one second 35% predicted) were studied at baseline (D0), 5–8 days (D5) and 3 months (3M) after starting NIV.

Results: Ventilator use was 6.2 (3.7) hours per night at D5 and 3.4 (1.6) at 3M (p = 0.12). Mean (SD) daytime arterial carbon-dioxide tension (PaCO2) was reduced from 7.4 (1.2) kPa to 7.0 (1.1) kPa at D5 and 6.5 (1.1) kPa at 3M (p = 0.001). Total lung capacity decreased from 107 (28) % predicted to 103 (28) at D5 and 103 (27) % predicted at 3M (p = 0.035). At D5 there was an increase in the hypercapnic ventilatory response and some volitional measures of inspiratory and expiratory muscle strength, but not isolated diaphragmatic strength whether assessed by volitional or nonvolitional methods.

Conclusion: These findings suggest decreased gas trapping and increased ventilatory sensitivity to CO2 are the principal mechanism underlying improvements in gas-exchange in patients with COPD following NIV. Changes in some volitional but not nonvolitional muscle strength measures may reflect improved patient effort.

Keywords: COPD; hypercapnic respiratory failure; NIV; pulmonary mechanics; ventilatory drive

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Evaluation of combined famotidine with quercetin for the treatment of peptic ulcer: in vivo animal study

Abourehab MA, Khaled KA, Sarhan HA, Ahmed OA

Drug Design, Development and Therapy 2015, 9:2159-2169

Published Date: 13 April 2015

Synthesis of talc/Fe3O4 magnetic nanocomposites using chemical co-precipitation method

Kalantari K, Bin Ahmad M, Shameli K, Khandanlou R

International Journal of Nanomedicine 2013, 8:1817-1823

Published Date: 15 May 2013

Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics

Liu L, Ma Y, Wang RL, Xu WR, Wang SQ, Chou KC

Drug Design, Development and Therapy 2013, 7:279-288

Published Date: 8 April 2013

Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections

Urbina O, Ferrández O, Espona M, Salas E, Ferrández I, Grau S

Drug Design, Development and Therapy 2013, 7:243-265

Published Date: 3 April 2013

Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups

Hong SC, Lee JH, Lee J, Kim HY, Park JY, Cho J, Lee J, Han DW

International Journal of Nanomedicine 2011, 6:3219-3231

Published Date: 7 December 2011

Treatment of respiratory failure in COPD

Stephan Budweiser, Rudolf A Jörres, Michael Pfeifer

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:605-618

Published Date: 9 December 2008

C-reactive protein correlates with tissue oxygen availability in patients with stable COPD

Simonetta Baldi, Gian Domenico Pinna1 Piera Mombaruzzo, Milena Biglieri, Angelo De Martini, Paolo Palange

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:745-751

Published Date: 12 September 2008

Tissue regeneration as next-generation therapy for COPD – potential applications

Shunsuke Ohnishi, Noritoshi Nagaya

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:509-514

Published Date: 26 August 2008